The 3rd International Healthcare and Finance Innovation Forum was held in Shanghai from November 23 to 24. Shanghai Health Development Research Center, Fudan University School of Management, and Health Futures China team jointly organized the event. The Forum also received supports from industry partners such as Pfizer, RGAX, Neusoft Viewhigh, and Nuohui Medical to discover the cutting edge topics related to social health insurance reform and health payment innovation.
The Forum consists four sessions: innovation on drug reimbursement policies, innovation on healthcare service payment, commercial insurance innovation, and disease based financing and payment innovation. More than sixty guest speakers shared their respective insights and innovative practices, including Representative of World Health Organization in China Dr. Gauden Galea, Director of Shanghai Municipal Health Commission Dr. Jinglei Wu, and Dean of School of Management of Fudan University Dr. Xiongwen Lu. The total audience exceeded four hundred and more than thirty journalists attended the event.
Health Futures research team together with Fudan University Healthcare and Finance Research Institute launched a white paper on Value Based Healthcare in China. It is the first white paper in China focusing on the cross sector collaboration and health system transformation built on the concept of value based healthcare. By documenting and analyzing innovative cases in China and abroad, the report reveals the key factors of value oriented health innovation in three sectors of drug and medical device, commercial insurance, and health information service. The report concludes with a detailed landing map for value based healthcare innovation in China.